US5478705A
(en)
*
|
1994-05-25 |
1995-12-26 |
Eastman Kodak Company |
Milling a compound useful in imaging elements using polymeric milling media
|
US5500331A
(en)
*
|
1994-05-25 |
1996-03-19 |
Eastman Kodak Company |
Comminution with small particle milling media
|
US5513803A
(en)
*
|
1994-05-25 |
1996-05-07 |
Eastman Kodak Company |
Continuous media recirculation milling process
|
US5718388A
(en)
*
|
1994-05-25 |
1998-02-17 |
Eastman Kodak |
Continuous method of grinding pharmaceutical substances
|
DE69527266T2
(de)
*
|
1994-07-26 |
2003-03-06 |
Sony Corp |
Verfahren zur bildübertragung
|
DE4440337A1
(de)
*
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
CA2213638C
(en)
|
1995-02-24 |
2004-05-04 |
Nanosystems L.L.C. |
Aerosols containing nanoparticle dispersions
|
US5474237A
(en)
*
|
1995-02-28 |
1995-12-12 |
Eastman Kodak Company |
Method and apparatus for eliminating screen plugging in wet grinding mills
|
US5834025A
(en)
*
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
US5662279A
(en)
*
|
1995-12-05 |
1997-09-02 |
Eastman Kodak Company |
Process for milling and media separation
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
AU6014098A
(en)
*
|
1996-12-31 |
1998-07-31 |
Inhale Therapeutic Systems |
Aerosolized hydrophobic drug
|
US20030203036A1
(en)
*
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US6045829A
(en)
*
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
WO1998035666A1
(en)
*
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
GB9703673D0
(en)
*
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
GB9726543D0
(en)
*
|
1997-12-16 |
1998-02-11 |
Smithkline Beecham Plc |
Novel compositions
|
US6086242A
(en)
*
|
1998-02-27 |
2000-07-11 |
University Of Utah |
Dual drive planetary mill
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
NZ511442A
(en)
*
|
1998-11-02 |
2003-02-28 |
Elan Corp Plc |
Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
US20070160675A1
(en)
*
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
US7919119B2
(en)
*
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6444223B1
(en)
*
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
ATE271922T1
(de)
*
|
1999-06-01 |
2004-08-15 |
Elan Pharma Int Ltd |
Kleinmühle und verfahren dafür
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
WO2001041760A2
(en)
*
|
1999-12-08 |
2001-06-14 |
Pharmacia Corporation |
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
|
EP1175434A2
(de)
*
|
1999-12-08 |
2002-01-30 |
Pharmacia Corporation |
Kristalline form von eplerenon
|
ES2303527T3
(es)
|
2000-05-10 |
2008-08-16 |
Jagotec Ag |
Procedimiento de molienda.
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
PL202623B1
(pl)
*
|
2000-06-28 |
2009-07-31 |
Smithkline Beecham Plc |
Sposób wytwarzania drobno zmielonego preparatu substancji leczniczej, drobno zmielona substancja lecznicza wytworzona tym sposobem i zawierająca ją kompozycja farmaceutyczna
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
EP1313451B1
(de)
|
2000-08-31 |
2009-03-11 |
Jagotec AG |
Gemahlene partikel
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US7998507B2
(en)
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US20040033267A1
(en)
*
|
2002-03-20 |
2004-02-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
GB0027357D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
WO2002043700A2
(en)
*
|
2000-11-30 |
2002-06-06 |
Vectura Limited |
Particles for use in a pharmaceutical composition
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6623761B2
(en)
|
2000-12-22 |
2003-09-23 |
Hassan Emadeldin M. |
Method of making nanoparticles of substantially water insoluble materials
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US6869617B2
(en)
*
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
FI20010115A0
(fi)
*
|
2001-01-18 |
2001-01-18 |
Orion Corp |
Menetelmä nanopartikkelien valmistamiseksi
|
IL156445A0
(en)
*
|
2001-01-26 |
2004-01-04 |
Schering Corp |
Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
WO2002098565A1
(en)
*
|
2001-06-05 |
2002-12-12 |
Elan Pharma International Limited |
System and method for milling materials
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
DE60203506T2
(de)
*
|
2001-06-22 |
2006-02-16 |
Marie Lindner |
Screening-verfahren mit hohem durchsatz (hts) unter verwendung von labormühlen oder microfluidics
|
US7758890B2
(en)
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
CA2460867C
(en)
*
|
2001-09-19 |
2011-04-12 |
Elan Pharma International Ltd. |
Nanoparticulate insulin formulations
|
WO2003026662A1
(en)
*
|
2001-09-25 |
2003-04-03 |
Pharmacia Corporation |
Solid-state forms of n-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
MXPA04002446A
(es)
*
|
2001-09-26 |
2004-07-23 |
Baxter Int |
Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
|
CA2463495C
(en)
|
2001-10-12 |
2011-05-24 |
Elan Pharma International Ltd. |
Compositions having a combination of immediate release and controlled release characteristics
|
US7112340B2
(en)
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
JP2005519657A
(ja)
*
|
2001-11-07 |
2005-07-07 |
インコール ファーマシューティカル カンパニー |
ナノ微粒子造影剤を用いた血管撮像の方法
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
CA2475092C
(en)
*
|
2002-02-04 |
2012-05-01 |
Christian F. Wertz |
Nanoparticulate compositions having lysozyme as a surface stabilizer
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
WO2003080023A2
(en)
*
|
2002-03-20 |
2003-10-02 |
Elan Pharma International Limited |
Fast dissolving dosage forms having reduced friability
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20050191357A1
(en)
*
|
2002-03-20 |
2005-09-01 |
Yoshiaki Kawashima |
Method of manufacturing chemical-containing composite particles
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
AU2003230885A1
(en)
|
2002-04-12 |
2003-10-27 |
Elan Pharma International Ltd. |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
AU2003234452A1
(en)
*
|
2002-05-06 |
2003-11-11 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7763278B2
(en)
*
|
2002-06-10 |
2010-07-27 |
Elan Pharma International Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
JP4776229B2
(ja)
*
|
2002-07-16 |
2011-09-21 |
エラン ファーマ インターナショナル,リミティド |
安定なナノ粒子活性物質の液体投与組成物
|
JP4878839B2
(ja)
*
|
2002-09-11 |
2012-02-15 |
エラン ファーマ インターナショナル,リミティド |
ゲル安定化ナノパーティクル活性物質組成物
|
CA2500908A1
(en)
*
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
US20040156895A1
(en)
*
|
2002-11-12 |
2004-08-12 |
Elan Pharma International Ltd. |
Solid dosage forms comprising pullulan
|
US20050095267A1
(en)
*
|
2002-12-04 |
2005-05-05 |
Todd Campbell |
Nanoparticle-based controlled release polymer coatings for medical implants
|
US20040173696A1
(en)
*
|
2002-12-17 |
2004-09-09 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
US7390505B2
(en)
*
|
2003-01-31 |
2008-06-24 |
Elan Pharma International, Ltd. |
Nanoparticulate topiramate formulations
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
JP5137228B2
(ja)
|
2003-03-07 |
2013-02-06 |
メルク・シャープ・アンド・ドーム・コーポレーション |
高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用
|
ATE418551T1
(de)
|
2003-03-07 |
2009-01-15 |
Schering Corp |
Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
|
US7140567B1
(en)
*
|
2003-03-11 |
2006-11-28 |
Primet Precision Materials, Inc. |
Multi-carbide material manufacture and use as grinding media
|
US7578457B2
(en)
*
|
2003-03-11 |
2009-08-25 |
Primet Precision Materials, Inc. |
Method for producing fine dehydrided metal particles using grinding media
|
US7842232B2
(en)
*
|
2003-05-22 |
2010-11-30 |
Elan Pharma International, Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
CA2534924A1
(en)
*
|
2003-08-08 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel metaxalone compositions
|
CA2537413A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Imran Ahmed |
Sustained release dosage forms of ziprasidone
|
US7879360B2
(en)
*
|
2003-11-05 |
2011-02-01 |
Elan Pharma International, Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
WO2005053851A1
(en)
*
|
2003-11-26 |
2005-06-16 |
E.I. Dupont De Nemours And Company |
High pressure media milling system and process of milling particles
|
US7722842B2
(en)
*
|
2003-12-31 |
2010-05-25 |
The Ohio State University |
Carbon dioxide sequestration using alkaline earth metal-bearing minerals
|
EP1559419A1
(de)
*
|
2004-01-23 |
2005-08-03 |
Fournier Laboratories Ireland Limited |
Pharmazeutische Darreichungsformen enthaltend Metformin und ein Fibrat, sowie deren Herstellungsprozesse
|
MX2007000308A
(es)
*
|
2004-07-01 |
2007-04-10 |
Warner Lambert Co |
Preparacion de composiciones farmaceuticas que contienen nanoparticulas.
|
EP1621200A1
(de)
*
|
2004-07-26 |
2006-02-01 |
Fournier Laboratories Ireland Limited |
Pharmazeutische Kombinationen enthaltend einen Hemmstoff der Plättchenaggregation und ein Fibrat
|
US20210299056A9
(en)
|
2004-10-25 |
2021-09-30 |
Varian Medical Systems, Inc. |
Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
|
US7910577B2
(en)
*
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
US20090155331A1
(en)
*
|
2005-11-16 |
2009-06-18 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
EP1835889A1
(de)
*
|
2004-12-15 |
2007-09-26 |
Elan Pharma International Limited |
Nanoteilchenförmige tacrolimus-formulierungen
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
BRPI0519739A2
(pt)
*
|
2004-12-30 |
2009-03-10 |
Cinv Ag |
combinaÇço compreendendo um agente fornecendo um sinal, um material de implante e uma droga
|
CA2594332A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Elan Pharma International Ltd. |
Nanoparticulate candesartan formulations
|
DE602005010747D1
(de)
*
|
2005-01-13 |
2008-12-11 |
Cinv Ag |
Kohlenstoffnanopartikel enthaltende verbundwerkstoffe
|
JP2008528722A
(ja)
*
|
2005-01-24 |
2008-07-31 |
シンベンション アーゲー |
金属含有コンポジット材料
|
EP2332524A1
(de)
|
2005-02-15 |
2011-06-15 |
Elan Pharma International Limited |
Aerosol und injizierbare Formulierung mit nanopartikulärem Benzodiazepin
|
US20080254114A1
(en)
*
|
2005-03-03 |
2008-10-16 |
Elan Corporation Plc |
Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
|
WO2006099121A2
(en)
*
|
2005-03-10 |
2006-09-21 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
|
BRPI0606283A2
(pt)
*
|
2005-03-16 |
2009-06-09 |
Elan Pharma Int Ltd |
formulações de antagonista de receptor de leucotrieno/corticosteróide em nanopartìcula
|
JP2008533173A
(ja)
*
|
2005-03-17 |
2008-08-21 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子ビスホスホネート組成物
|
CA2598840A1
(en)
*
|
2005-03-18 |
2006-09-21 |
Cinvention Ag |
Process for the preparation of porous sintered metal materials
|
US8003127B2
(en)
*
|
2005-03-23 |
2011-08-23 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
US8309133B2
(en)
*
|
2005-04-12 |
2012-11-13 |
Alkermes Pharma Ireland Limited |
Nanoparticulate quinazoline derivative formulations
|
CN101171000A
(zh)
*
|
2005-04-12 |
2008-04-30 |
依兰药物国际有限公司 |
包含环孢菌素的毫微粒和控制释放组合物
|
US20080305161A1
(en)
*
|
2005-04-13 |
2008-12-11 |
Pfizer Inc |
Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
|
WO2006132752A1
(en)
*
|
2005-05-10 |
2006-12-14 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
WO2007070082A1
(en)
*
|
2005-05-10 |
2007-06-21 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising teprenone
|
KR20080008403A
(ko)
*
|
2005-05-10 |
2008-01-23 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 클로피도그렐 제제
|
BRPI0614080A2
(pt)
*
|
2005-05-16 |
2017-07-25 |
Elan Pharma Int Ltd |
Composição e método para a preparação de uma cefalosporina nanoparticulada, para o tratamento de doença bacteriana e para a prevenção e/ou tratamento de osteoporose
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
CN101262860A
(zh)
*
|
2005-06-03 |
2008-09-10 |
伊兰制药国际有限公司 |
纳米微粒对乙酰氨基酚制剂
|
JP2008542397A
(ja)
|
2005-06-03 |
2008-11-27 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子メシル酸イマチニブ製剤
|
US20070042049A1
(en)
*
|
2005-06-03 |
2007-02-22 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
JP2009517485A
(ja)
|
2005-06-08 |
2009-04-30 |
エラン・ファルマ・インターナショナル・リミテッド |
セフジトレンを含むナノ粒子状および制御放出組成物
|
CA2611475A1
(en)
*
|
2005-06-09 |
2006-12-21 |
Elan Pharma International, Limited |
Nanoparticulate ebastine formulations
|
EP1906973A2
(de)
*
|
2005-06-14 |
2008-04-09 |
Baxter International Inc. |
Pharmazeutische formulierungen zur minimierung von arzneimittel-wechselwirkungen
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
WO2006138421A2
(en)
*
|
2005-06-15 |
2006-12-28 |
Elan Pharma International Limited |
Nanoparticulate azelnidipine formulations
|
CN101879140A
(zh)
*
|
2005-06-20 |
2010-11-10 |
依兰药物国际有限公司 |
包含芳基-杂环化合物的毫微粒和控制释放组合物
|
JP2008545026A
(ja)
*
|
2005-07-01 |
2008-12-11 |
シンベンション アーゲー |
多孔性網状化複合材料の作製のためのプロセス
|
MX2008000131A
(es)
*
|
2005-07-01 |
2008-04-04 |
Cinv Ag |
Dispositivos medicos que comprenden un material compuesto reticulado.
|
WO2007008537A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
BRPI0614267A2
(pt)
*
|
2005-08-10 |
2012-01-24 |
Novartis Ag |
composição de nanopartìculas de 7-t-butóxiiminometilcamptotecina, seu método de produção e uso das referidas nanopartìculas
|
GB0516549D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sulaiman Brian |
Milling system
|
US20070104792A1
(en)
*
|
2005-09-13 |
2007-05-10 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
JP2009508859A
(ja)
|
2005-09-15 |
2009-03-05 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アリピプラゾール製剤
|
BRPI0617450A2
(pt)
*
|
2005-10-18 |
2011-07-26 |
Cinv Ag |
partÍculas de termocura e mÉtodos para produÇço das mesmas
|
US20070098803A1
(en)
|
2005-10-27 |
2007-05-03 |
Primet Precision Materials, Inc. |
Small particle compositions and associated methods
|
AU2006315177A1
(en)
*
|
2005-11-15 |
2007-05-24 |
Baxter Healthcare S.A. |
Compositions of lipoxygenase inhibitors
|
ES2812250T3
(es)
|
2005-11-28 |
2021-03-16 |
Marinus Pharmaceuticals Inc |
Formulaciones de ganaxolona y procedimientos para la preparación y uso de las mismas
|
ES2395392T3
(es)
|
2005-12-29 |
2013-02-12 |
Lexicon Pharmaceuticals, Inc. |
Derivados aminoácidos multicíclicos y métodos de su uso
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
AU2007224006A1
(en)
*
|
2006-03-07 |
2007-09-13 |
Novavax, Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
US8231907B2
(en)
|
2006-03-21 |
2012-07-31 |
Morehouse School Of Medicine |
Nanoparticles for delivery of active agents
|
CA2653504A1
(en)
*
|
2006-05-30 |
2007-12-13 |
Elan Pharma International Ltd. |
Nanoparticulate posaconazole formulations
|
AU2007264418B2
(en)
*
|
2006-06-30 |
2012-05-03 |
Iceutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
NZ599069A
(en)
*
|
2006-06-30 |
2013-10-25 |
Iceutica Pty Ltd |
Methods for the Preparation of Biologically Active Compounds in Nanoparticulate Form
|
EP2049084A2
(de)
*
|
2006-07-10 |
2009-04-22 |
Elan Pharma International Limited |
Nanoteilchenförmige sorafenib-formulierungen
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
WO2008066899A2
(en)
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
UA99270C2
(en)
|
2006-12-12 |
2012-08-10 |
Лексикон Фармасьютикалз, Инк. |
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
|
US20090152176A1
(en)
*
|
2006-12-23 |
2009-06-18 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
CN101646402A
(zh)
*
|
2007-01-19 |
2010-02-10 |
金文申有限公司 |
用粉末模塑法制成的多孔、不可降解植入物
|
PL2120878T3
(pl)
*
|
2007-02-09 |
2015-01-30 |
Alphapharm Pty Ltd |
Postać dawkowania zawierająca dwa czynne składniki farmaceutyczne o różnych postaciach fizycznych
|
US20080206862A1
(en)
*
|
2007-02-28 |
2008-08-28 |
Cinvention Ag |
High surface cultivation system bag
|
CA2677699A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Cinvention Ag |
High surface cultivation system
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
EP2095816A1
(de)
*
|
2008-02-29 |
2009-09-02 |
Schlichthaar, Rainer, Dr. |
Nanosuspension mit antifungaler Wirkung zur Verabreichung mittels Inhalation mit verbessertem Unreinheitsprofil und erhöhter Sicherheit
|
WO2009117401A2
(en)
*
|
2008-03-21 |
2009-09-24 |
Elan Pharama International Limited |
Compositions for site-specific delivery of imatinib and methods of use
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
EP3666858A3
(de)
|
2008-09-26 |
2020-08-19 |
The Ohio State University |
Verfahren zur herstellung von keramischen verbundteilchen
|
EP2389159A1
(de)
|
2009-01-22 |
2011-11-30 |
Noramco, Inc. |
Verfahren zur herstellung von opioid-partikeln und so hergestellte zusammensetzungen
|
EP2398499B1
(de)
|
2009-02-18 |
2017-09-06 |
Eyeon Particle Sciences LLC |
Verwendung von bifunktionellem copolymer für augenärztliche und andere topische sowie lokale anwendungen
|
EP3045043B1
(de)
|
2009-02-26 |
2020-04-29 |
Relmada Therapeutics, Inc. |
Oral einnehmbare pharmazeutische zusammensetzungen aus 3-hydroxy-n-methylmorphinan mit verzögerter freisetzung und verwendungsverfahren dafür
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
CN105663045A
(zh)
*
|
2009-04-24 |
2016-06-15 |
伊休蒂卡有限公司 |
高体积分数的包封纳米颗粒的制备
|
AP2015008955A0
(en)
|
2009-04-24 |
2015-12-31 |
Icuetica Pty Ltd |
A novel formulation of indomethacin
|
CN103830243A
(zh)
*
|
2009-04-24 |
2014-06-04 |
伊休蒂卡有限公司 |
用于改善生物活性物质溶出度特征的方法
|
MA33295B1
(fr)
|
2009-04-24 |
2012-05-02 |
Iceutica Pty Ltd |
Nouvelle formulation de diclofénac
|
UA110773C2
(uk)
*
|
2009-04-24 |
2016-02-25 |
Айсьютіка Пті Лтд |
Спосіб одержання порошків, що містять нано- і мікрочастинки
|
MY177537A
(en)
*
|
2009-04-24 |
2020-09-17 |
Iceutica Pty Ltd |
Production of encapsulated nanoparticles at commercial scale
|
WO2010138539A2
(en)
|
2009-05-27 |
2010-12-02 |
Elan Pharma International Ltd. |
Reduction of flake-like aggregation in nanoparticulate active agent compositions
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
ES2554626T3
(es)
|
2009-06-12 |
2015-12-22 |
Cynapsus Therapeutics Inc. |
Apomorfina sublingual
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
AU2010292313B2
(en)
|
2009-09-08 |
2015-08-20 |
The Ohio State University Research Foundation |
Integration of reforming/water splitting and electrochemical systems for power generation with integrated carbon capture
|
CA2773457C
(en)
|
2009-09-08 |
2018-08-28 |
The Ohio State University Research Foundation |
Synthetic fuels and chemicals production with in-situ co2 capture
|
CN102711749A
(zh)
|
2009-11-05 |
2012-10-03 |
莱西肯医药有限公司 |
用于癌症治疗的色氨酸羟化酶抑制剂
|
WO2011100285A1
(en)
|
2010-02-10 |
2011-08-18 |
Lexicon Pharmaceuticals, Inc. |
Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
|
US10463633B2
(en)
|
2010-04-23 |
2019-11-05 |
Kempharm, Inc. |
Therapeutic formulation for reduced drug side effects
|
WO2011146583A2
(en)
|
2010-05-19 |
2011-11-24 |
Elan Pharma International Limited |
Nanoparticulate cinacalcet formulations
|
EP2618818A4
(de)
|
2010-09-22 |
2014-10-29 |
Map Pharmaceuticals Inc |
Corticosteroidpartikel und herstellungsverfahren dafür
|
WO2012064712A1
(en)
|
2010-11-08 |
2012-05-18 |
The Ohio State University |
Circulating fluidized bed with moving bed downcomers and gas sealing between reactors
|
ES2791715T3
(es)
|
2010-12-16 |
2020-11-05 |
Sunovion Pharmaceuticals Inc |
Películas sublinguales
|
US9808030B2
(en)
|
2011-02-11 |
2017-11-07 |
Grain Processing Corporation |
Salt composition
|
EP2707350A4
(de)
|
2011-05-11 |
2015-12-23 |
Ohio State Innovation Foundation |
Systeme zum umwandeln von brennstoffen
|
EP3584426B1
(de)
|
2011-05-11 |
2021-04-14 |
Ohio State Innovation Foundation |
Sauerstoffträgermaterialien
|
WO2013016156A1
(en)
|
2011-07-22 |
2013-01-31 |
Glaxo Group Limited |
Polymorphic forms of the sodium salt of 4-tert- butyl -n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
|
RU2607515C2
(ru)
|
2011-07-22 |
2017-01-10 |
Хемоцентрикс, Инк. |
Кристаллическая форма натриевой соли 4-трет-бутил-n-{ 4-хлор-2-(1-окси-пиридин-4-карбонил)-фенил} -бензолсульфонамид
|
WO2013030374A1
(en)
|
2011-09-01 |
2013-03-07 |
Glaxo Group Limited |
Novel crystal form
|
WO2013059676A1
(en)
|
2011-10-21 |
2013-04-25 |
Subhash Desai |
Compositions for reduction of side effects
|
EP2780009A4
(de)
|
2011-11-17 |
2015-05-06 |
Univ Colorado Regents |
Verfahren und zusammensetzungen zur verbesserten wirkstofffreisetzung ins auge und formulierungen mit verlängerter freisetzung
|
WO2013142258A1
(en)
|
2012-03-22 |
2013-09-26 |
Nanotherapeutics, Inc. |
Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles
|
US20130303763A1
(en)
|
2012-03-30 |
2013-11-14 |
Michael D. Gershon |
Methods and compositions for the treatment of necrotizing enterocolitis
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US9056057B2
(en)
|
2012-05-03 |
2015-06-16 |
Kala Pharmaceuticals, Inc. |
Nanocrystals, compositions, and methods that aid particle transport in mucus
|
KR102154880B1
(ko)
|
2012-05-03 |
2020-09-10 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
JP6306013B2
(ja)
|
2012-08-21 |
2018-04-04 |
クラトス・エル・エル・シー |
官能化iva族粒子およびその使用方法
|
US9461309B2
(en)
|
2012-08-21 |
2016-10-04 |
Kratos LLC |
Group IVA functionalized particles and methods of use thereof
|
JP6033055B2
(ja)
*
|
2012-11-26 |
2016-11-30 |
クリニプロ株式会社 |
吸入用パウダーの製造方法
|
JP6091862B2
(ja)
*
|
2012-11-26 |
2017-03-08 |
クリニプロ株式会社 |
吸入用パウダーの製造方法
|
CA3148322A1
(en)
|
2013-02-05 |
2014-08-14 |
Ohio State Innovation Foundation |
Methods for converting fuel into syngas
|
AU2014216178B2
(en)
|
2013-02-15 |
2018-06-28 |
KALA BIO, Inc. |
Therapeutic compounds and uses thereof
|
AU2014219024B2
(en)
|
2013-02-20 |
2018-04-05 |
KALA BIO, Inc. |
Therapeutic compounds and uses thereof
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
US9616403B2
(en)
|
2013-03-14 |
2017-04-11 |
Ohio State Innovation Foundation |
Systems and methods for converting carbonaceous fuels
|
CA2913611C
(en)
|
2013-06-28 |
2019-12-24 |
Rexahn Pharmaceuticals, Inc. |
Nanoparticulate compositions and formulations of piperazine compounds
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
MX355330B
(es)
|
2013-11-01 |
2018-04-16 |
Kala Pharmaceuticals Inc |
Formas cristalinas de compuestos terapeuticos y sus usos.
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
JP2017513787A
(ja)
*
|
2014-02-21 |
2017-06-01 |
クラトス・エル・エル・シー |
官能基化第iva族粒子の構造体のためのナノシリコン材料の調製
|
WO2015131117A1
(en)
|
2014-02-27 |
2015-09-03 |
Ohio State Innovation Foundation |
Systems and methods for partial or complete oxidation of fuels
|
WO2015134608A1
(en)
|
2014-03-05 |
2015-09-11 |
Nanotherapeutics, Inc. |
Compositions and methods for oral delivery of encapsulated 3-aminopyridine-2-carboxaldehyde particles
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
WO2015198229A1
(en)
|
2014-06-25 |
2015-12-30 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
|
JP2016035913A
(ja)
*
|
2014-07-31 |
2016-03-17 |
富士フイルム株式会社 |
全固体二次電池、ならびに、無機固体電解質粒子、固体電解質組成物、電池用電極シートおよび全固体二次電池の製造方法
|
JP6571166B2
(ja)
|
2014-08-18 |
2019-09-04 |
アルカーメス ファーマ アイルランド リミテッド |
アリピプラゾールプロドラッグ組成物
|
US10016415B2
(en)
|
2014-08-18 |
2018-07-10 |
Alkermes Pharma Ireland Limited |
Aripiprazole prodrug compositions
|
WO2016038519A1
(en)
|
2014-09-08 |
2016-03-17 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
|
US10166197B2
(en)
|
2015-02-13 |
2019-01-01 |
St. John's University |
Sugar ester nanoparticle stabilizers
|
JP7211706B2
(ja)
|
2015-04-21 |
2023-01-24 |
サノヴィオン ファーマシュティカルズ インコーポレーテッド |
口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法
|
CN107709344B
(zh)
|
2015-05-01 |
2022-07-15 |
共晶制药股份有限公司 |
用于治疗黄病毒科病毒和癌症的核苷类似物
|
EP3362042A1
(de)
|
2015-10-16 |
2018-08-22 |
Marinus Pharmaceuticals, Inc. |
Injizierbare neurosteroidformulierungen mit nanopartikeln
|
WO2017143017A1
(en)
|
2016-02-17 |
2017-08-24 |
Alkermes Pharma Ireland Limited |
Compositions of multiple aripiprazole prodrugs
|
US11111143B2
(en)
|
2016-04-12 |
2021-09-07 |
Ohio State Innovation Foundation |
Chemical looping syngas production from carbonaceous fuels
|
CA3029244A1
(en)
|
2016-07-05 |
2018-01-11 |
Kratos LLC |
Passivated pre-lithiated micron and sub-micron group iva particles and methods of preparation thereof
|
US20180042903A1
(en)
|
2016-08-11 |
2018-02-15 |
Ovid Therapeutics Inc. |
Methods and compositions for treatment of epileptic disorders
|
JP6891715B2
(ja)
*
|
2016-08-23 |
2021-06-18 |
住友金属鉱山株式会社 |
試料作製方法および試料分析方法
|
AU2017324716B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
EP3509421A4
(de)
|
2016-09-08 |
2020-05-20 |
Kala Pharmaceuticals, Inc. |
Kristalline formen therapeutischer verbindungen und verwendungen davon
|
EP3509422A4
(de)
|
2016-09-08 |
2020-05-20 |
Kala Pharmaceuticals, Inc. |
Kristalline formen von therapeutischen verbindungen und verwendungen davon
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
WO2018052053A1
(ja)
|
2016-09-13 |
2018-03-22 |
協和発酵キリン株式会社 |
医薬組成物
|
WO2018129555A1
(en)
|
2017-01-09 |
2018-07-12 |
Temple University - Of The Commonwealth System Of Higher Education |
Methods and compositions for treatment of non-alcoholic steatohepatitis
|
WO2018183909A1
(en)
|
2017-03-31 |
2018-10-04 |
Kratos LLC |
Precharged negative electrode material for secondary battery
|
CN111065459B
(zh)
|
2017-07-31 |
2023-09-22 |
俄亥俄州立创新基金会 |
具有不相等反应器组件运行压力的反应器系统
|
US10549236B2
(en)
|
2018-01-29 |
2020-02-04 |
Ohio State Innovation Foundation |
Systems, methods and materials for NOx decomposition with metal oxide materials
|
US11413574B2
(en)
|
2018-08-09 |
2022-08-16 |
Ohio State Innovation Foundation |
Systems, methods and materials for hydrogen sulfide conversion
|
KR20210090606A
(ko)
*
|
2018-11-29 |
2021-07-20 |
베즈미아렘 바키프 유니버시테시 |
점토 첨가제 나노미립자를 얻는 방법
|
WO2020118142A1
(en)
|
2018-12-07 |
2020-06-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of pospartum depression
|
JP7121290B2
(ja)
*
|
2019-02-15 |
2022-08-18 |
住友金属鉱山株式会社 |
試料作製方法および試料分析方法
|
WO2020179701A1
(ja)
|
2019-03-01 |
2020-09-10 |
塩野義製薬株式会社 |
異物を低減したナノ粒子組成物およびその製法
|
US11453626B2
(en)
|
2019-04-09 |
2022-09-27 |
Ohio State Innovation Foundation |
Alkene generation using metal sulfide particles
|
KR102072968B1
(ko)
*
|
2019-05-28 |
2020-02-04 |
주식회사 울트라브이 |
생분해성 고분자 미세 입자의 제조 방법 및 조직 수복용 생분해성 재료
|
CA3145923A1
(en)
|
2019-08-05 |
2021-02-11 |
David Czekai |
Ganaxolone for use in treatment of status epilepticus
|
US20220287985A1
(en)
|
2019-08-16 |
2022-09-15 |
Hiroshima Metal & Machinery Co., Ltd |
Organic nanoparticle production method and organic nanoparticles
|
JP2022551863A
(ja)
|
2019-10-11 |
2022-12-14 |
コーバス ファーマシューティカルズ インコーポレーテッド |
アジュレミン酸の組成物及びその使用
|
MX2022006014A
(es)
|
2019-12-06 |
2022-06-22 |
Marinus Pharmaceuticals Inc |
Ganaxolona para uso en el tratamiento del complejo de esclerosis tuberosa.
|
EP3928772A1
(de)
|
2020-06-26 |
2021-12-29 |
Algiax Pharmaceuticals GmbH |
Nanopartikuläre zusammensetzung
|